Back to Report Store Home

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

  • Published: Aug-2018
  • Report Code: GBIHC044IDB
  • Report Format: pdf

Description

List of Figures

Figure 1: Number of Products under Development for Pancreatic Cancer

Figure 2: Number of Products under Development by Companies, Pancreatic Cancer

Figure 3: Number of Products under Development by Universities/Institutes, Pancreatic Cancer

Figure 4: Number of Products under Development for Bile Duct Cancer (Cholangiocarcinoma)

Figure 5: Number of Products under Development by Companies, Bile Duct Cancer (Cholangiocarcinoma)

Figure 6: Number of Products under Development by Universities/Institutes, Bile Duct Cancer (Cholangiocarcinoma)

Figure 7: Number of Products by Top 10 Targets, Pancreatic Cancer

Figure 8: Number of Products by Stage and Top 10 Targets, Pancreatic Cancer

Figure 9: Number of Products by Top 10 Mechanism of Actions, Pancreatic Cancer

Figure 10: Number of Products by Stage and Top 10 Mechanism of Actions, Pancreatic Cancer

Figure 11: Number of Products by Top 10 Routes of Administration, Pancreatic Cancer

Figure 12: Number of Products by Stage and Top 10 Routes of Administration, Pancreatic Cancer

Figure 13: Number of Products by Top 10 Molecule Types, Pancreatic Cancer

Figure 14: Number of Products by Stage and Top 10 Molecule Types, Pancreatic Cancer

Figure 15: Number of Products by Top 10 Targets, Bile Duct Cancer (Cholangiocarcinoma)

Figure 16: Number of Products by Stage and Top 10 Targets, Bile Duct Cancer (Cholangiocarcinoma)

Figure 17: Number of Products by Top 10 Mechanism of Actions, Bile Duct Cancer (Cholangiocarcinoma)

Figure 18: Number of Products by Stage and Top 10 Mechanism of Actions, Bile Duct Cancer (Cholangiocarcinoma)

Figure 19: Number of Products by Routes of Administration, Bile Duct Cancer (Cholangiocarcinoma)

Figure 20: Number of Products by Stage and Routes of Administration, Bile Duct Cancer (Cholangiocarcinoma)

Figure 21: Number of Products by Top 10 Molecule Types, Bile Duct Cancer (Cholangiocarcinoma)

Figure 22: Number of Products by Stage and Top 10 Molecule Types, Bile Duct Cancer (Cholangiocarcinoma)

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards